cdmo.directory
← Compare landing

Dipharma vs Laurus Labs

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/dipharma/lauruslabs

CategoryDipharmaLaurus Labs
Listed sitecdmocdmo
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.Global pharmaceutical company specializing in APIs, formulations, and CDMO services for small molecule and biologics.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Small Molecule
  • Biologics (Other)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
Data not yet provided.
CertificationsData not yet provided.
  • FDA · Identifier: US FDA Audit - API Manufacturing Facility at Hyderabad
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.